{"id":3061,"date":"2017-08-14T12:51:15","date_gmt":"2017-08-14T12:51:15","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/clinical-research-hyperthermia-andromedic\/"},"modified":"2026-02-02T21:43:22","modified_gmt":"2026-02-02T21:43:22","slug":"essais-cliniques-hyperthermie-rf","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/fr\/essais-cliniques-hyperthermie-rf\/","title":{"rendered":"Essais cliniques"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/\",\n      \"logo\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/cropped-andromedic_logo.webp\",\n      \"description\": \"Andromedic Srl est un leader mondial dans le d\u00e9veloppement et la fabrication d'\u00e9quipements \u00e9lectrom\u00e9dicaux de pointe pour l'hyperthermie oncologique, incluant le dispositif HyDeep 600 WM.\",\n      \"address\": {\n        \"@type\": \"PostalAddress\",\n        \"addressLocality\": \"Velletri\",\n        \"addressCountry\": \"IT\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#srho\",\n      \"name\": \"SRHO - Soci\u00e9t\u00e9 Roumaine d'Hyperthermie Oncologique\",\n      \"alternateName\": \"RSHO - Romanian Society of Oncological Hyperthermia\",\n      \"url\": \"https:\/\/hyperthermiaro.com\",\n      \"description\": \"Autorit\u00e9 scientifique en hyperthermie oncologique. Fond\u00e9e par M.Sc. Cristian Gologan et la Dre Veronica Iatan.\",\n      \"memberOf\": [\n        { \"@type\": \"Organization\", \"name\": \"European Society for Hyperthermic Oncology (ESHO)\" }\n      ]\n    },\n    {\n      \"@type\": \"Organization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#premium-wellness\",\n      \"name\": \"Premium Wellness Distrib SRL\",\n      \"description\": \"Partenaire officiel et distributeur des dispositifs d'hyperthermie RF locale d'Andromedic Srl.\",\n      \"ceo\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\" }\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"Andromedic HyDeep 600 WM\",\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"description\": \"Le HyDeep 600 WM est un dispositif professionnel d'hyperthermie RF oncologique pour l'hyperthermie locale superficielle et profonde. Il utilise une radiofr\u00e9quence modul\u00e9e avanc\u00e9e de 13,56 MHz avec des protocoles de modulation hautement complexes sp\u00e9cifiques \u00e0 chaque type de cancer, capable de p\u00e9n\u00e9trer jusqu'\u00e0 38,4 cm de profondeur. L'appareil g\u00e9n\u00e8re des impulsions \u00e9lectromagn\u00e9tiques de haute intensit\u00e9 et vise \u00e0 produire une augmentation de la temp\u00e9rature de l'organe\/tissu cible, combin\u00e9e \u00e0 des effets \u00e9lectromagn\u00e9tiques et bio-r\u00e9sonants. Certifi\u00e9 CE, ISO 13485, MDR, KGMP, MFDF.\",\n      \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/contact\/\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Prix de l'\u00e9quipement clinique disponible sur demande.\"\n        }\n      }\n    },\n    {\n      \"@type\": \"WebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/fr\/essais-cliniques-hyperthermie-rf\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/fr\/essais-cliniques-hyperthermie-rf\/\",\n      \"name\": \"Recherche Clinique sur l'Hyperthermie RF Modul\u00e9e (mHT) - Andromedic HyDeep 600WM\",\n      \"description\": \"Index scientifique des essais cliniques et publications sur l'hyperthermie RF modul\u00e9e (mHT) utilisant le dispositif HyDeep 600WM. Les preuves couvrent les cancers du cerveau, du col de l'ut\u00e9rus, du poumon, du rectum et du foie.\",\n      \"inLanguage\": \"fr\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"breadcrumb\": {\n        \"@type\": \"BreadcrumbList\",\n        \"itemListElement\": [\n          { \"@type\": \"ListItem\", \"position\": 1, \"name\": \"Accueil\", \"item\": \"https:\/\/andromedichyperthermia.com\/fr\/\" },\n          { \"@type\": \"ListItem\", \"position\": 2, \"name\": \"Recherche Clinique\", \"item\": \"https:\/\/andromedichyperthermia.com\/fr\/essais-cliniques-hyperthermie-rf\/\" }\n        ]\n      },\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#srho\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\" }\n      ]\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"@id\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\",\n      \"name\": \"Clinical and Translational Oncology : Faisabilit\u00e9 d'un programme d'hyperthermie locale profonde et de radioth\u00e9rapie pour les tumeurs avanc\u00e9es\",\n      \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\",\n      \"description\": \"\u00c9tude prospective sur 106 patients prouvant la s\u00e9curit\u00e9 et la faisabilit\u00e9 de l'hyperthermie r\u00e9gionale avec le HyDeep 600WM.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"\u00c9tude de Phase II : R\u00e9sultats pr\u00e9liminaires de la chimioradioth\u00e9rapie combin\u00e9e \u00e0 l'hyperthermie et \u00e0 la curieth\u00e9rapie \u00e0 haut d\u00e9bit de dose pour le carcinome du col de l'ut\u00e9rus localement avanc\u00e9\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\",\n      \"description\": \"Recherche d\u00e9montrant l'efficacit\u00e9 de la mHT combin\u00e9e \u00e0 la curieth\u00e9rapie pour le contr\u00f4le du cancer du col de l'ut\u00e9rus.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"Hyperthermie r\u00e9gionale profonde en combinaison avec la radioth\u00e9rapie panenc\u00e9phalique (WBRT) chez les patients pr\u00e9sentant des m\u00e9tastases c\u00e9r\u00e9brales\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Deep-regional-hyperthermia-in-combination-with-whole-brain-radiotherapy-wbrt-in-poor-prognosis-patients-with-brain-metastases.pdf\",\n      \"description\": \"\u00c9tude clinique sur les m\u00e9tastases c\u00e9r\u00e9brales montrant une am\u00e9lioration de la survie sans progression (PFS) et de la survie globale (OS) par hyperthermie locale profonde.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"\u00c9tude de quasi-faisabilit\u00e9 (cas-t\u00e9moins) associant l'hyperthermie locale profonde aux traitements oncologiques standards - Poster ESHO\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/poster-ESHO-15.pdf\",\n      \"description\": \"\u00c9tude cas-t\u00e9moins d\u00e9crivant les mod\u00e8les de r\u00e9ponse dans les cancers rectaux et abdominaux avec le syst\u00e8me HyDeep 600WM.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"Atelier sur l'Hyperthermie RF Modul\u00e9e (mHT) : Protocoles cliniques et \u00e9tudes de cas\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\",\n      \"description\": \"Pr\u00e9sentation scientifique d\u00e9taillant les protocoles RF modul\u00e9s pour des traitements sp\u00e9cifiques aux pathologies.\"\n    },\n    {\n      \"@type\": \"ScholarlyArticle\",\n      \"name\": \"Effets synergiques de l'Hyperthermie RF Modul\u00e9e en Oncologie (MDPI)\",\n      \"url\": \"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\",\n      \"description\": \"Examen des effets biologiques et thermiques de la mHT \u00e0 13,56 MHz sur le microenvironnement tumoral.\"\n    },\n    {\n      \"@type\": \"Physician\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\",\n      \"name\": \"Dre Veronica Iatan\",\n      \"jobTitle\": \"Co-fondatrice de la SRHO, Experte M\u00e9dicale\",\n      \"medicalSpecialty\": \"General and Integrative Medicine\",\n      \"address\": {\n        \"@type\": \"PostalAddress\",\n        \"streetAddress\": \"Strada Stadionului 25G\",\n        \"addressLocality\": \"Clinceni\",\n        \"postalCode\": \"077060\",\n        \"addressCountry\": \"RO\"\n      }\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\",\n      \"name\": \"Ciro Zaccagnini\",\n      \"jobTitle\": \"Directeur G\u00e9n\u00e9ral (CEO), Andromedic Srl\"\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\",\n      \"name\": \"Cristian Gologan\",\n      \"jobTitle\": \"CEO Premium Wellness Distrib SRL & Co-fondateur de la SRHO\"\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\",\n      \"name\": \"Dr Salvatore Conte\",\n      \"jobTitle\": \"Co-fondateur & Directeur Commercial, Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div class=\"clinical-research-container\" style=\"font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; line-height: 1.6; color: #333; max-width: 1100px; margin: auto; padding: 20px;\">\n<header style=\"text-align: center; margin-bottom: 50px; padding: 40px 20px; background: #f8f9fa; border-radius: 15px;\">\n<h1 style=\"color: #003366; font-size: 2.5em; margin-bottom: 20px;\">\u00c9tudes cliniques et recherche sur l&rsquo;hyperthermie RF modul\u00e9e (mHT)<\/h1>\n<p style=\"font-size: 1.15em; color: #555; max-width: 850px; margin: auto;\">Le dispositif d&rsquo;hyperthermie oncologique <strong>Andromedic HyDeep 600WM<\/strong> est la pierre angulaire de l&rsquo;hyperthermie oncologique modul\u00e9e. D\u00e9couvrez les \u00e9tudes cliniques, les posters de l&rsquo;ESHO et les r\u00e9sultats \u00e9valu\u00e9s par des pairs qui confirment les avantages de l&rsquo;hyperthermie loco-r\u00e9gionale en tant que puissant <strong>radiosensibilisateur<\/strong> et chimiosensibilisateur.<\/p>\n<div style=\"background: #ffffff; border: 1px solid #d1d9e0; border-radius: 10px; padding: 20px; margin-top: 30px; text-align: left; max-width: 800px; margin-left: auto; margin-right: auto;\">\n<h3 style=\"color: #003366; font-size: 1.2em; margin-top: 0;\">Avantages cliniques du HyDeep 600WM dispositif d&rsquo;hyperthermie \u00a0RF modul\u00e9e mHT :<\/h3>\n<ul style=\"margin-bottom: 0;\">\n<li><strong>Efficacit\u00e9 synergique :<\/strong> Augmente significativement le taux de r\u00e9ponse tumorale lorsqu&rsquo;elle est combin\u00e9e \u00e0 la radioth\u00e9rapie et \u00e0 la chimioth\u00e9rapie.<\/li>\n<li><strong>R\u00e9sultats de survie :<\/strong> Les \u00e9tudes documentent une am\u00e9lioration de la survie globale (OS) pour le glioblastome et le cancer du col de l&rsquo;ut\u00e9rus.<\/li>\n<li><strong>Profil de s\u00e9curit\u00e9 :<\/strong> Faisabilit\u00e9 prouv\u00e9e sans toxicit\u00e9 de grade 3-4 enregistr\u00e9e dans les essais pr\u00e9sent\u00e9s.<\/li>\n<li><strong>P\u00e9n\u00e9tration profonde :<\/strong> Distribution thermique efficace dans les organes cibles jusqu&rsquo;\u00e0 une profondeur de 38,4 cm.<\/li>\n<\/ul>\n<\/div>\n<\/header>\n<section id=\"Featured_Trials\" style=\"margin-bottom: 60px;\">\n<h2 style=\"text-align: center; color: #003366; border-bottom: 3px solid #0056b3; display: inline-block; padding-bottom: 10px; margin-bottom: 40px;\">\u00c9tudes cliniques s\u00e9lectionn\u00e9es avec le syst\u00e8me d&rsquo;hyperthermie locale profonde HyDeep 600WM<\/h2>\n<div class=\"trial-card\" style=\"background: #fff; border: 1px solid #e0e0e0; border-radius: 12px; padding: 30px; margin-bottom: 30px; box-shadow: 0 4px 15px rgba(0,0,0,0.05);\">\n<h3 style=\"color: #0056b3;\"><a style=\"text-decoration: none; color: inherit;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\" target=\"_blank\" rel=\"noopener\">Clinical and Translational Oncology : \u00c9tude de faisabilit\u00e9 sur les tumeurs avanc\u00e9es<\/a><\/h3>\n<p><strong>Contexte :<\/strong> \u00c9tude clinique prospective (EudraCT 2018-001089-40) \u00e9valuant la s\u00e9curit\u00e9 de l&rsquo;hyperthermie locale profonde avec radioth\u00e9rapie via le <strong>dispositif d&rsquo;hyperthermie RF modul\u00e9e HyDeep 600WM<\/strong> \u00e0 13,56 MHz.<\/p>\n<blockquote style=\"border-left: 5px solid #2ecc71; background: #f9fff9; padding: 15px; font-style: italic; margin: 20px 0;\"><p>\u00ab\u00a0L&rsquo;hyperthermie loco-r\u00e9gionale est une technique r\u00e9alisable et s\u00fbre pouvant \u00eatre utilis\u00e9e en association avec la radioth\u00e9rapie et les traitements syst\u00e9miques. 86,8 % des patients ont termin\u00e9 toutes les s\u00e9ances pr\u00e9vues.\u00a0\u00bb<\/p><\/blockquote>\n<p><a style=\"background: #0056b3; color: #fff; padding: 10px 20px; border-radius: 5px; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger le PDF complet<\/a><br \/>\n<a style=\"color: #0056b3; font-weight: bold; margin-left: 15px;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31102061\/\" target=\"_blank\" rel=\"noopener\">Voir sur PubMed<\/a><\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 25px; margin-bottom: 40px;\">\n<div style=\"border: 1px solid #eee; padding: 15px; border-radius: 10px; text-align: center;\">\n<p><img decoding=\"async\" style=\"width: 100%; border-radius: 5px;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" alt=\"\u00c9tude clinique de faisabilit\u00e9 HyDeep 600WM chez des patients atteints de cancer avanc\u00e9\" title=\"\"><\/p>\n<p style=\"font-size: 0.9em; margin-top: 10px;\"><strong>\u00c9tude de quasi-faisabilit\u00e9 (Cas-T\u00e9moins) &#8211; Hyperthermie profonde (Syst\u00e8me d&rsquo;hyperthermie locale profonde HyDeep 600WM) et traitement oncologique standard<\/strong><\/p>\n<p><a href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/cartleESHOfinal.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger le PDF<\/a><\/p>\n<\/div>\n<div style=\"border: 1px solid #eee; padding: 15px; border-radius: 10px; text-align: center;\">\n<p><img decoding=\"async\" style=\"width: 100%; border-radius: 5px;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" alt=\"Poster ESHO profils de r\u00e9ponse utilisant l&#039;hyperthermie RF HyDeep 600WM avec chimioradioth\u00e9rapie\" title=\"\"><\/p>\n<p style=\"font-size: 0.9em; margin-top: 10px;\"><strong>Poster ESHO : Mod\u00e8les de r\u00e9ponse &#8211; Hyperthermie (<b data-path-to-node=\"2,2,0\" data-index-in-node=\"0\">Dispositif m\u00e9dical d&rsquo;hyperthermie<\/b>\u00a0 HyDeep 600WM) et chimio\/radioth\u00e9rapie<\/strong><\/p>\n<p><a href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/poster-ESHO-15.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger le PDF<\/a><\/p>\n<\/div>\n<\/div>\n<div class=\"trial-card\" style=\"background: #fff; border: 1px solid #e0e0e0; border-radius: 12px; padding: 30px; margin-bottom: 30px;\">\n<h3 style=\"color: #c0392b;\">Cancer du col de l&rsquo;ut\u00e9rus localement avanc\u00e9 (LACC)<\/h3>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone\" style=\"max-width: 400px; display: block; margin: 15px auto; border-radius: 5px;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" alt=\"R\u00e9sultats cliniques de l&#039;hyperthermie RF modul\u00e9e pour le cancer du col de l&#039;ut\u00e9rus -Essais cliniques\" width=\"590\" height=\"837\" title=\"\"><br \/>\n<strong>R\u00e9sultat : Tous les patients ont obtenu un contr\u00f4le local.<\/strong> La combinaison de cisplatine hebdomadaire, d&rsquo;hyperthermie RF modul\u00e9e (HyDeep 600WM) et de brachyth\u00e9rapie n&rsquo;a montr\u00e9 aucune toxicit\u00e9 de grade 3-4.<\/p>\n<p><a style=\"color: #c0392b; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger Poster ESHO PDF<\/a><\/p>\n<\/div>\n<div style=\"background: #eef4f8; border-radius: 12px; padding: 30px;\">\n<section id=\"Clinical_trials\" style=\"margin-bottom: 60px;\">\n<div style=\"background: #eef4f8; border-radius: 12px; padding: 30px; margin-bottom: 40px;\">\n<h4 style=\"text-align: center; color: #003366;\">Hyperthermie r\u00e9gionale profonde en association avec la radioth\u00e9rapie c\u00e9r\u00e9brale totale (WBRT)<\/h4>\n<div style=\"padding: 10px 20px;\"><strong>R\u00e9sum\u00e9 :<\/strong> Pour la premi\u00e8re fois, le r\u00f4le de l&rsquo;hyperthermie profonde r\u00e9gionale a \u00e9t\u00e9 \u00e9valu\u00e9 pour les patients atteints de m\u00e9tastases c\u00e9r\u00e9brales \u00e0 mauvais pronostic (GPI\u22642,5).<br \/>\n<strong>R\u00e9sultats :<\/strong> La tol\u00e9rance \u00e9tait excellente et aucune toxicit\u00e9 n&rsquo;a \u00e9t\u00e9 enregistr\u00e9e. Les patients ayant un temps de traitement HT efficace sup\u00e9rieur \u00e0 la m\u00e9diane ont montr\u00e9 une meilleure PFS \u00e0 6 et 12 mois.<br \/>\n<strong>Conclusions :<\/strong> L&rsquo;hyperthermie profonde semble plus facile \u00e0 mettre en \u0153uvre et plus s\u00fbre que les proc\u00e9dures perop\u00e9ratoires complexes. La survie globale (OS) m\u00e9diane a \u00e9t\u00e9 am\u00e9lior\u00e9e \u00e0 6 mois.<a style=\"font-weight: bold; color: #003366;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Deep-regional-hyperthermia-in-combination-with-whole-brain-radiotherapy-wbrt-in-poor-prognosis-patients-with-brain-metastases.pdf\" target=\"_blank\" rel=\"noopener\">Lire le texte complet &#8211; Hyperthermie et m\u00e9tastases c\u00e9r\u00e9brales <\/a><\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; background: #fff; border: 1px solid #eee; padding: 35px; border-radius: 12px;\">\n<h2 style=\"text-align: center; color: #003366;\">\u00c9tudes cliniques compl\u00e9mentaires sur l&rsquo;hyperthermie mHT<\/h2>\n<p style=\"text-align: center; font-size: 1.1em;\">L&rsquo;hyperthermie RF modul\u00e9e (mHT) en tant que th\u00e9rapie <strong>adjuvante, n\u00e9oadjuvante et palliative<\/strong> est au c\u0153ur de recherches approfondies.<\/p>\n<div style=\"text-align: center; margin-top: 25px; padding: 20px; background: #f0f7ff; border-radius: 8px;\">\n<p style=\"color: #000080; margin-bottom: 10px;\"><strong>L&rsquo;avis de l&rsquo;expert &#8211; Prof. Dr Giammaria Fiorentini :<\/strong><\/p>\n<p><a style=\"font-weight: bold; color: #0056b3; font-size: 1.1em;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\" target=\"_blank\" rel=\"noopener\">Hyperthermie \u2013 R\u00e9sultats des \u00e9tudes cliniques r\u00e9centes et rapports de cas (Rome, 2023)<\/a><\/p>\n<p style=\"margin-top: 15px;\"><a style=\"text-decoration: underline;\" href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\" target=\"_blank\" rel=\"noopener\">Validation clinique de la mHT &#8211; Revue r\u00e9cente (2023)<\/a><\/p>\n<p style=\"color: #000080; margin-bottom: 10px; margin-top: 20px;\"><strong>Lectures recommand\u00e9es &#8211; Dr Veronica Iatan :<\/strong><\/p>\n<ul style=\"text-align: left; display: inline-block;\">\n<li><strong><a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-quality-of-life-qol\/\">Impact de l&rsquo;hyperthermie sur la qualit\u00e9 de vie (QoL) : soulagement de la douleur et b\u00e9n\u00e9fices immunitaires<\/a><\/strong><\/li>\n<li><strong><a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-survival-cancer-patients\/\">Hyperthermie et survie des patients : preuves cliniques montrant une augmentation de l&rsquo;OS de plus de 50 %<\/a><\/strong><\/li>\n<li><strong><a href=\"https:\/\/andromedichyperthermia.com\/oncologic-hyperthermia-phase-3-trials\/\">Int\u00e9gration th\u00e9rapeutique de l&rsquo;hyperthermie en oncologie : analyse critique des \u00e9tudes de phase III et m\u00e9ta-analyses<\/a><\/strong><\/li>\n<\/ul>\n<\/div>\n<\/section>\n<section id=\"Scientific_Library\" style=\"margin-bottom: 60px;\">\n<h2 style=\"text-align: center; color: #003366; margin-bottom: 30px;\">Publications scientifiques : Recherche en hyperthermie<\/h2>\n<div style=\"background: #fff; border-radius: 12px; border: 1px solid #eee; padding: 10px 25px;\">\n<ul style=\"list-style: none; padding-left: 0;\">\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Hyperthermie r\u00e9gionale combin\u00e9e \u00e0 la radioth\u00e9rapie pour le cancer du col de l&rsquo;ut\u00e9rus : essai randomis\u00e9 prospectif de l&rsquo;AIEA<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/25_REG1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Nouvelle strat\u00e9gie d&rsquo;hyperthermie RF (n\u00e9othermie) combin\u00e9e \u00e0 la chimioradioth\u00e9rapie pr\u00e9op\u00e9ratoire pour le cancer du rectum avanc\u00e9<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/24_Shoji_et_al-2015-Cancer_Medicine.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Effets immunologiques de l&rsquo;hyperthermie locale chez les patients atteints d&rsquo;un cancer primitif du foie<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/23_Immune-related-Effects-of-Local-Hyperthermia-in-Patients-with-Primary-Liver-Cancer.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">R\u00e9irradiation plus hyperthermie r\u00e9gionale pour le cancer du poumon non \u00e0 petites cellules r\u00e9current<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/22_RE-1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Hyperthermie capacitive 8 MHz et radioth\u00e9rapie pour le cancer du poumon stade III : corr\u00e9lation entre puissance RF et r\u00e9sultats<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/20_RAD1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Hyperthermie r\u00e9gionale profonde de la r\u00e9gion thoracique : relation entre puissance RF et temp\u00e9rature endo-\u0153sophagienne (59 patients)<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/19_Deep-regional-hyperthermia-for-the-whole-thoracic-region-using-8-MHz-radiofrequency-capacitive-heating-device.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Hyperthermie combin\u00e9e \u00e0 la chimioth\u00e9rapie pour les patients atteints de cancer de l&rsquo;\u0153sophage r\u00e9siduel ou r\u00e9current<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/18_nishimura-oesophageal-cancer.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Radioth\u00e9rapie d\u00e9finitive plus hyperthermie r\u00e9gionale pour les tumeurs du sulcus sup\u00e9rieur : exp\u00e9rience de 20 ans<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/17_DEF1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">\u00c9tude de faisabilit\u00e9 de l&rsquo;hyperthermochemoth\u00e9rapie intrap\u00e9riton\u00e9ale postop\u00e9ratoire pour le cancer gastrique avanc\u00e9<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/16_FEA1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Guide d&rsquo;assurance qualit\u00e9 pour les essais cliniques d&rsquo;hyperthermie superficielle (I &amp; II)<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Quality-assurance-guidelines-for-superficial-hyperthermiaclinical-trials.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Effet des propri\u00e9t\u00e9s tumorales sur l&rsquo;absorption d&rsquo;\u00e9nergie et la dose thermique en hyperthermie RF 13,56 MHz<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/12_EFF1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Hyperthermie combin\u00e9e \u00e0 la radioth\u00e9rapie dans les maladies localement avanc\u00e9es r\u00e9currentes ou m\u00e9tastatiques<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/11_OP14_Maluta_Hyperthermie-combined-with-Radiotherapy-in-locally-advanced-recurrent-or-metastatic-disease-1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Utilit\u00e9 des plaques isolantes mobiles pour optimiser la zone de chauffage profond<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/10_THE1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Hyperthermie locor\u00e9gionale des tumeurs profondes avec syst\u00e8mes capacitifs et radiatifs : \u00e9tude de simulation<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/9_LOC1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Chimioth\u00e9rapie \u00e0 base de bevacizumab combin\u00e9e \u00e0 l&rsquo;hyperthermie capacitive r\u00e9gionale profonde<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/8_gadaleta-bevacizumab-HT.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Comparaison des caract\u00e9ristiques de chauffage de l&rsquo;hyperthermie superficielle capacitive et radiative<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/7_COM1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Assurance qualit\u00e9 : Directives pour le chauffage s\u00fbr des patients porteurs d&rsquo;implants m\u00e9talliques<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/6_QUAL1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Thermo-chimio-radioth\u00e9rapie pour le carcinome des voies biliaires avanc\u00e9<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/5_kamisawa-bile-duct.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Mod\u00e8le num\u00e9rique pour l&rsquo;hyperthermie capacitive RF r\u00e9gionale profonde dans les tumeurs pelviennes<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Numerical-model-for-deep-regional-RF-capacitive-hyperthermia-in-pelvic-tumors.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Am\u00e9lioration de la r\u00e9ponse \u00e0 la douleur pendant la radioth\u00e9rapie palliative des m\u00e9tastases osseuses<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/1_DIEK1.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">R\u00e9sultats pr\u00e9liminaires de chimioradioth\u00e9rapie plus hyperthermie et brachyth\u00e9rapie HDR pour LACC<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0; border-bottom: 1px solid #f0f0f0;\">\n<p style=\"margin: 0;\">Faisabilit\u00e9 de l&rsquo;hyperthermie profonde locale en combinaison avec les traitements oncologiques standards<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/CTO-ExperiencianHipertermia-Las-Palmas-Marzo-2019.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<li style=\"padding: 15px 0;\">\n<p style=\"margin: 0;\">\u00c9tude de quasi-faisabilit\u00e9 (cas-t\u00e9moins) associant l&rsquo;hyperthermie profonde aux traitements standards<\/p>\n<p><a style=\"font-size: 0.9em; color: #0056b3; font-weight: bold;\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\" target=\"_blank\" rel=\"noopener\">[ T\u00e9l\u00e9charger PDF ]<\/a><\/li>\n<\/ul>\n<\/div>\n<\/section>\n<section id=\"Guidelines\" style=\"margin-bottom: 60px; background: #34495e; color: #fff; padding: 40px; border-radius: 12px;\">\n<div>\n<h3 style=\"text-align: center; border-bottom: 2px solid #white; padding-bottom: 15px; margin-bottom: 30px;\"><span style=\"color: #ffffff; background-color: #34495e; font-size: 20px;\">Directives cliniques et assurance qualit\u00e9<\/span><\/h3>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 20px;\"><a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/6_QUAL1.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Patients avec implants m\u00e9talliques<\/a><br \/>\n<a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Linee-guida-HT-.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Directives pour l&rsquo;hyperthermie profonde<\/a><br \/>\n<a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Guide-to-the-use-of-hyperthermic-equipment-1-Capacitivelycoupled-heating.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Guide d&rsquo;utilisation de l&rsquo;\u00e9quipement<\/a><br \/>\n<a style=\"color: #ecf0f1; text-decoration: none; padding: 15px; border: 1px solid #5d6d7e; border-radius: 8px; text-align: center;\" href=\"https:\/\/andromedic.it\/wp-content\/uploads\/2023\/02\/Quality-assurance-guidelines-for-superficial-hyperthermiaclinical-trials.pdf\" target=\"_blank\" rel=\"noopener\">&#x2714;&#xfe0f; Guide QA Hyperthermie Superficielle<\/a><\/div>\n<\/section>\n<footer style=\"text-align: center; border-top: 2px solid #eee; padding-top: 40px;\">\n<h3>Besoin des r\u00e9sultats d\u00e9taill\u00e9s des \u00e9tudes cliniques ?<\/h3>\n<p>Contactez nos experts pour obtenir le dossier clinique complet du syst\u00e8me HyDeep 600WM.<\/p>\n<p><a style=\"background: #c0392b; color: #fff; padding: 15px 35px; border-radius: 30px; text-decoration: none; font-weight: bold; display: inline-block; margin-top: 20px; font-size: 1.1em;\" href=\"https:\/\/andromedichyperthermia.com\/fr\/contactez-andromedic-france\/\">Demander un support clinique<\/a><\/p>\n<\/footer>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00c9tudes cliniques et recherche sur l&rsquo;hyperthermie RF modul\u00e9e (mHT) Le dispositif d&rsquo;hyperthermie oncologique Andromedic HyDeep 600WM est la pierre angulaire de l&rsquo;hyperthermie oncologique modul\u00e9e. D\u00e9couvrez les \u00e9tudes cliniques, les posters de l&rsquo;ESHO et les r\u00e9sultats \u00e9valu\u00e9s par des pairs qui confirment les avantages de l&rsquo;hyperthermie loco-r\u00e9gionale en tant que puissant radiosensibilisateur et chimiosensibilisateur. Avantages cliniques&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1707,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-3061","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/pages\/3061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/comments?post=3061"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/pages\/3061\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/media\/1707"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/media?parent=3061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}